ADMA Biologics Inc.
(ADMA)
undefined
undefined%
At close: undefined
18.43
-0.79%
After-hours Dec 13, 2024, 07:49 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Net Income | -28.24M | -65.90M | -71.65M | -75.75M | -48.28M | -65.74M | -43.76M | -19.52M | -17.97M | -16.81M | -15.53M | -7.30M | -26.46K | -20.53K | -20.01M | -24.89M | -29.69M |
| Depreciation & Amortization | 8.33M | 7.11M | 5.50M | 3.94M | 3.26M | 3.45M | 2.69M | 469.58K | 469.82K | 247.85K | 210.63K | 182.09K | - | 220.00K | - | - | - |
| Stock-Based Compensation | 6.19M | 5.21M | 3.49M | 2.86M | 2.65M | - | 1.56M | 1.25M | 1.71M | 1.25M | 888.29K | 626.79K | - | - | - | - | - |
| Other Working Capital | 7.58M | 6.40M | 5.49M | 2.56M | -49.36K | -167.69K | -821.50K | 183.53K | 1.30M | 1.54M | 2.19M | -35.13K | -2.54K | 850.00 | 10.49M | -17.89M | - |
| Other Non-Cash Items | 32.64M | 12.35M | 1.75M | 1.64M | 1.04M | 961.33K | 638.73K | 534.11K | 390.54K | 359.66K | 146.87K | 7.47K | - | -220.00K | -14.94M | 23.78M | 1.49M |
| Deferred Income Tax | - | - | 220.76K | -910.10K | -1.36M | 122.19K | 1.88M | - | 651.24K | 74.36K | -43.29K | 18.40K | - | - | - | - | - |
| Change in Working Capital | -10.12M | -18.29M | -51.68M | -33.78M | -33.50M | -3.69M | -282.24K | -1.01M | -671.12K | 177.93K | 3.44M | -437.23K | -2.54K | 850.00 | 10.49M | -17.89M | 4.58M |
| Operating Cash Flow | 8.80M | -59.51M | -112.37M | -102.00M | -76.19M | -62.68M | -37.27M | -18.27M | -15.42M | -14.70M | -10.89M | -6.90M | -29.00K | -19.68K | -24.46M | -19.00M | -23.61M |
| Capital Expenditures | -4.98M | -13.91M | -13.51M | -12.73M | -3.81M | -2.10M | -2.68M | -73.41K | -26.07K | -2.32M | -196.63K | -118.85K | - | - | - | - | - |
| Acquisitions | - | - | - | 2.00K | - | - | 12.50M | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | -12.50M | -15.68M | -1.72M | -1.72M | -2.94M | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | 5.39M | 16.66M | - | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | -210.00K | - | - | 2.00K | - | - | 12.50M | - | - | - | - | - | - | - | - | - | - |
| Investing Cash Flow | -4.98M | -13.91M | -13.51M | -12.72M | -3.81M | -2.10M | 15.21M | 904.58K | -1.74M | -4.04M | -3.13M | -118.85K | - | - | - | - | - |
| Debt Repayment | -23.60M | 51.71M | -34.00K | 13.52M | 42.47M | -36.28K | 24.98M | 3.98M | 685.38K | 9.84M | 988.43K | 3.70M | - | - | - | - | - |
| Common Stock Repurchased | -1.42M | - | - | - | - | - | - | - | - | - | - | -150.00K | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | -3.91M | - | - | - | - | - |
| Other Financial Acitivies | -13.97M | -7.51M | -62.00K | -816.57K | 37.53M | 13.01K | -3.43M | -47.10K | 9.72M | -42.14K | -772.95K | -1.36M | 1.29M | 23.00K | 30.50M | 7.00M | 12.50K |
| Financial Cash Flow | -38.99M | 108.85M | 121.05M | 143.90M | 80.00M | 42.92M | 60.75M | 16.84M | 10.40M | 9.80M | 27.63M | 19.47M | 25.50K | 23.00K | 30.50M | 7.00M | 12.50M |
| Net Cash Flow | -35.17M | 35.43M | -4.83M | 29.17M | -2.72K | -21.85M | 38.69M | -526.09K | -6.76M | -8.95M | 13.61M | 12.45M | -3.50K | 3.32K | 6.04M | -12.01M | -11.12M |
| Free Cash Flow | 3.82M | -73.42M | -125.88M | -114.73M | -80.01M | -64.77M | -39.95M | -18.34M | -15.44M | -17.03M | -11.08M | -7.02M | -29.00K | -19.68K | -24.46M | -19.00M | -23.61M |